Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Statement of Comprehensive Income 

Pfizer Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income before allocation to noncontrolling interests 2,158 31,407 22,025 9,652 16,302
Foreign currency translation adjustments, net 485 (2,204) (725) 1,036 400
Reclassification adjustments (17) (288)
Foreign currency translation adjustments 485 (2,204) (725) 1,019 112
Unrealized holding gains (losses) on derivative financial instruments, net 514 1,261 442 (494) 393
Reclassification adjustments for (gains) losses included in net income (320) (1,792) 105 46 (539)
Derivative financial instruments 194 (531) 547 (448) (146)
Unrealized holding gains (losses) on available-for-sale securities, net (106) (1,142) (311) 316 (1)
Reclassification adjustments for (gains) losses included in net income (123) 1,583 (26) (164) 34
Available-for-sale securities (229) 441 (337) 152 33
Actuarial gains (losses), net (847) (657)
Reclassification adjustments related to amortization 214 186
Reclassification adjustments related to settlements, net 213 209
Other (183) 31
Actuarial gains (losses) (603) (231)
Prior service (costs) credits and other, net (20) (19) 89 40 (6)
Reclassification adjustments related to amortization of prior service costs and other, net (89) (100) (107) (145) (138)
Reclassification adjustments related to curtailments of prior service costs and other, net (11) (9) (57) (1)
Other (1) 1
Prior service (costs) credits and other (120) (128) (75) (106) (144)
Benefit plans (120) (128) (75) (709) (375)
Other comprehensive income (loss) before allocation to noncontrolling interests 330 (2,422) (590) 14 (376)
Comprehensive income before allocation to noncontrolling interests 2,488 28,985 21,435 9,666 15,926
Comprehensive income attributable to noncontrolling interests (26) (20) (42) (27) (18)
Comprehensive income attributable to Pfizer Inc. 2,462 28,965 21,393 9,639 15,908

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income attributable to Pfizer Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Pfizer Inc. net income attributable to Pfizer Inc. increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Comprehensive income attributable to Pfizer Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Pfizer Inc. comprehensive income attributable to Pfizer Inc. increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.